Willard Dere's Trading History
| BMRNBioMarin Pharmaceutical | Jun 04, 2026 | Director | Uninformative Buy | ― | $2.72M | |
| MRSNMersana Therapeutics | Jan 06, 2026 | ― | Uninformative Sell | ― | $0.00 | |
| ~RDUSRadius Health | Aug 15, 2022 | ― | Uninformative Sell | 231.95K | $0.00 | |
| MCRBSeres Therapeutics | Jul 06, 2022 | Director | Uninformative Buy | 100.00K | $56.19K | |
| RDUSSchnitzer Steel Industries | Feb 13, 2019 | ― | Uninformative Buy | 116.64K | $144.00K | |
| OCRXOcera Therapeutics | Dec 11, 2017 | ― | Uninformative Sell | 19.00K | $0.00 | |
| MGXMetagenomi, Inc. | ― | Director | ― | ― | ||
| AMGNAmgen | ― | Sr. V.P., Global Dev & CMO | ― | $4.45M |
You May Also Like
Willard Dere insider profile FAQ
What stocks does Willard Dere hold?
Willard Dere holds: MCRB, AMGN, BMRN, RDUS, OCRX, MRSN, MGX, ~RDUS stocks.
What was Willard Dere’s latest transaction?
Willard Dere’s latest transaction was an Uninformative Buy of $100.00K.
What is Willard Dere's role in Seres Therapeutics?
Willard Dere's role in Seres Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.